Oncology
MOMA Therapeutics and Roche sign cancer drug discovery deal
MOMA Therapeutics and Roche have signed a strategic partnership and licencing agreement for discovering drug targets for cancer. Under the…
AbbVie and Umoja to develop new CAR-T therapies for cancer
AbbVie has entered a strategic partnership with Umoja Biopharma for the development of new in-situ chimeric antigen receptor (CAR)-T cell…
Boehringer and 3T Biosciences partner to develop cancer immunotherapies
Boehringer Ingelheim has signed a strategic partnership and licencing agreement with 3T Biosciences for the discovery and development of next-generation…
BridGene and Galapagos partner for oncology drugs discovery
BridGene Biosciences has entered a strategic partnership and licensing deal with Galapagos for the discovery of new small-molecule drug candidates…
Diakonos’ brain tumour vaccine wins FDA’s orphan drug designation
The US Food and Drug Administration (FDA) has granted orphan drug designation to Diakonos’ dendritic cell vaccine DOC1021 for malignant…
EMA validates BMS’s repotrectinib application to treat cancer
The European Medicines Agency (EMA) has validated the marketing authorisation application of Bristol Myers Squibb (BMS) for repotrectinib to treat…
MediLink and Roche partner on cancer drug development
MediLink Therapeutics has signed a global partnership and licence deal with Roche to develop a next-generation antibody-drug conjugate (ADC), YL211,…
TMC and IDRS Labs introduce oral therapy for leukaemia in India
Experts from Tata Memorial Hospital, Mumbai, India, and the Advanced Centre for Training Research and Education in Cancer (ACTREC) have…
BMS bags advanced melanoma win for Opdualag in the UK
The UK Medicines and Healthcare products Regulatory Agency (MHRA) announced the approval of Bristol Myers Squibb’s Opdualag (nivolumab and relatlimab)…
J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem
Johnson & Johnson Innovative Medicine (J&J) has entered into a licensing agreement with South Korean LegoChem Biosciences to develop and…
